Shockwave has completed the DISRUPT BTK clinical study, demonstrating the effectiveness and safety of IVL in small diameter, difficult-to-treat BTK arteries - no procedural complications, low residual stenosis and no TLR at 30 days in severely calcified CLI patients.
Looking for careers? Click here.